{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:29:03Z","timestamp":1747942143484,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cabrini Foundation Sambor Family Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A third of patients with advanced cancer and bone metastasis suffer from cancer induced bone pain (CIBP), impeding quality of life, psychological distress, depression and anxiety. This study will evaluate the impact of an opioid rotation, comparing methadone rotation with other opioid rotation in patients with refractory CIBP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This open-label randomised controlled trial will recruit cancer patients with CIBP and inadequate pain control despite established baseline opioid and\/or intolerable opioid side effects from cancer and palliative care services. Participants will be at least 18\u00a0years old, with a predicted prognosis of greater than 8\u00a0weeks, meet the core diagnostic criteria for CIBP, have a worst pain score of\u2009\u2265\u20094 of 10 from CIBP and\/ or have opioid toxicity (graded\u2009\u2265\u20092 on Common Terminology Criteria for Adverse Events). Participants will have sufficiently proficient English to complete questionnaires and provide informed consent.<\/jats:p>\n                <jats:p>Participants will be randomised 1:1 to be rotated to methadone to another opioid. The primary objective is to examine the impact of opioid rotation in improving CIBP by comparing analgesic efficacy, safety and tolerability in the two arms. Secondary objectives will assess changes in the intensity, duration and frequency of breakthrough pain, requirement of breakthrough analgesia, overall opioid escalation index, and time taken to observe improvement in pain reduction, pain interference and quality of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Laboratory studies suggest the involvement of neuropathic involvement in the mechanism of CIBP, though there remains no clear evidence of the routine use of neuropathic agents. Methadone as an analgesic agent may have a role to play in this cohort of patients, thus warranting further exploratory studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration<\/jats:title>\n                <jats:p>Australian New Zealand Clinical Trials Registry No: ACTRN12621000141842. Registered 11 February 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-023-01160-1","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T01:01:58Z","timestamp":1681520518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-1258","authenticated-orcid":false,"given":"Natasha","family":"Michael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlina","family":"Sulistio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wojnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"publisher","first-page":"h315","DOI":"10.1136\/bmj.h315","volume":"350","author":"CM Kane","year":"2015","unstructured":"Kane CM, Hoskin P, Bennett MI. Cancer induced bone pain. BMJ. 2015;350:h315.","journal-title":"BMJ"},{"issue":"3","key":"1160_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165\u201376.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"1160_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clon.2011.03.003","volume":"23","author":"T Middlemiss","year":"2011","unstructured":"Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol. 2011;23(6):387\u201392.","journal-title":"Clin Oncol"},{"issue":"23","key":"1160_CR4","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/ijms20236047","volume":"20","author":"R Zajaczkowska","year":"2019","unstructured":"Zajaczkowska R, Kocot-Kepska M, Leppert W, Wordliczek J. Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci. 2019;20(23):6047.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1160_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.hoc.2018.01.005","volume":"32","author":"MP Davis","year":"2018","unstructured":"Davis MP. Cancer-related neuropathic pain: review and selective topics. Hematol Oncol Clin North Am. 2018;32(3):417\u201331.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"1160_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2015.63.8221","volume":"34","author":"M Fallon","year":"2016","unstructured":"Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, et al. Randomized double-blind trial of Pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain. J Clin Oncol. 2016;34(6):550\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1160_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker KA, Davis MP, Reddy A, Paice J, et al. Safe and appropriate use of methadone in hospice and palliative care: Expert Consensus White Pape. J Pain Symptom Manage. 2019;57(3):635\u201345 e63.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1160_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00520-020-05606-7","volume":"29","author":"M Sulistio","year":"2021","unstructured":"Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubaie Z, Michael N. The role of methadone in cancer-induced bone pain: a retrospective cohort study. Support Care Cancer. 2021;29(3):1327\u201335.","journal-title":"Support Care Cancer"},{"key":"1160_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00520-015-2678-9","volume":"23","author":"B Afsharimani","year":"2015","unstructured":"Afsharimani B, Kindl K, Good P, et al. Pharmacological options for the management of refractory cancer pain\u2014what is the evidence? Support Care Cancer. 2015;23:1473\u201381.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1160_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1160_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/sjpain-2018-0012","volume":"18","author":"ISK Thong","year":"2018","unstructured":"Thong ISK, Jensen MP, Miro J, Tan G. The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain. 2018;18(1):99\u2013107.","journal-title":"Scand J Pain"},{"issue":"1","key":"1160_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch E, Becker C, Rogak LJ, Schrag D, Reeve BB, Spears P, et al. Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021;18(1):104\u201314.","journal-title":"Clin Trials"},{"issue":"2","key":"1160_CR13","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58-68.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1160_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2016.10.020","volume":"18","author":"JA Paice","year":"2017","unstructured":"Paice JA, Mulvey M, Bennett M, Dougherty PM, Farrar JT, Mantyh PW, et al. AAPT diagnostic criteria for chronic cancer pain conditions. J Pain. 2017;18(3):233\u201346.","journal-title":"J Pain"},{"issue":"Suppl 4","key":"1160_CR15","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv166\u201391.","journal-title":"Ann Oncol"},{"issue":"2","key":"1160_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","volume":"50","author":"S McLean","year":"2015","unstructured":"McLean S, Twomey F. Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manage. 2015;50(2):248\u201359 e241.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"1160_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/0269216311406577","volume":"25","author":"S Mercadante","year":"2011","unstructured":"Mercadante S, Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med. 2011;25(5):504\u201315.","journal-title":"Palliat Med"},{"issue":"4","key":"1160_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13\u201324.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"11","key":"1160_CR19","doi-asserted-by":"publisher","first-page":"e0187961","DOI":"10.1371\/journal.pone.0187961","volume":"12","author":"H Timmerman","year":"2017","unstructured":"Timmerman H, Steegers MAH, Huygen F, Goeman JJ, van Dasselaar NT, Schenkels MJ, Wilder-Smith OHG, Wolff AP, Vissers KCP. Investigating the validity of the DN4 in a consecutive population of patients with chronic pain. PLoS ONE. 2017;12(11):e0187961.","journal-title":"PLoS ONE"},{"issue":"3","key":"1160_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"1","key":"1160_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/j.pain.0000000000001700","volume":"161","author":"R LoMartire","year":"2020","unstructured":"LoMartire R, Ang BO, Gerdle B, Vixner L. Psychometric properties of Short Form-36 Health Survey, EuroQol 5-dimensions, and Hospital Anxiety and Depression Scale in patients with chronic pain. Pain. 2020;161(1):83\u201395.","journal-title":"Pain"},{"key":"1160_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-684X-4-7","volume":"4","author":"AP Abernethy","year":"2005","unstructured":"Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice. BMC Palliat Care. 2005;4:7.","journal-title":"BMC Palliat Care"},{"issue":"4","key":"1160_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jpainsymman.2013.10.026","volume":"48","author":"K Webber","year":"2014","unstructured":"Webber K, Davies AN, Zeppetella G, Cowie MR. Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. J Pain Symptom Manage. 2014;48(4):619\u201331.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1160_CR24","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"1160_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/ADT.0000000000000093","volume":"15","author":"JJ Westermeyer","year":"2016","unstructured":"Westermeyer JJ, Yoon G, Thuras P, Batres-Y-Carr T, Dickmann P. Pharmacotherapy in methadone maintenance: Clinical utility of peak-trough blood levels. Addict Disord Their Treat. 2016;15(4):157\u201364.","journal-title":"Addict Disord Their Treat"},{"issue":"4","key":"1160_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0885-3924(96)00302-8","volume":"13","author":"S Mercadante","year":"1997","unstructured":"Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A. Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symp Manage. 1997;13(4):204\u201312.","journal-title":"J Pain Symp Manage"},{"issue":"8","key":"1160_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","volume":"12","author":"S Mercadante","year":"2008","unstructured":"Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12(8):1040\u20136.","journal-title":"Eur J Pain"},{"issue":"2","key":"1160_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","volume":"18","author":"DI Cubero","year":"2010","unstructured":"Cubero DI, del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer. 2010;18(2):235\u201342.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1160_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057\u201373.","journal-title":"Stat Methods Med Res"},{"key":"1160_CR30","volume-title":"Stata Statistical Software: Release 16","author":"StataCorp.","year":"2019","unstructured":"StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019."}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01160-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-023-01160-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-023-01160-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T01:02:03Z","timestamp":1681520523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-023-01160-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1186\/s12904-023-01160-1","relation":{},"ISSN":["1472-684X"],"issn-type":[{"type":"electronic","value":"1472-684X"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Monash Health Research Ethics Committee (Reference Number RES-20-0000869C) and Cabrini Research Governance Office (Reference Number 07\u201304-03\u201321). Participants will only be enrolled into the study if they provide written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as the manuscript does not contain data from any individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}